Cargando…
The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome
PURPOSE: To assess the distribution of births and spontaneous abortions, first-trimester abortion (FTA) and mid-trimester abortion (MTA), in untreated (n=128) and low molecular weight heparin (LMWH) treated pregnancies (n=50) of the same women with inherited thrombophilias and adverse pregnancy outc...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960391/ https://www.ncbi.nlm.nih.gov/pubmed/27401656 http://dx.doi.org/10.3349/ymj.2016.57.5.1230 |
_version_ | 1782444521495199744 |
---|---|
author | Aracic, Nada Roje, Damir Jakus, Ivana Alujevic Bakotin, Marinela Stefanovic, Vedran |
author_facet | Aracic, Nada Roje, Damir Jakus, Ivana Alujevic Bakotin, Marinela Stefanovic, Vedran |
author_sort | Aracic, Nada |
collection | PubMed |
description | PURPOSE: To assess the distribution of births and spontaneous abortions, first-trimester abortion (FTA) and mid-trimester abortion (MTA), in untreated (n=128) and low molecular weight heparin (LMWH) treated pregnancies (n=50) of the same women with inherited thrombophilias and adverse pregnancy outcome (APO) in previous pregnancies. We particularly investigated the impact of LMWH on reducing the pregnancy complications in two thrombophilia types, "Conventional" and "Novel". MATERIALS AND METHODS: 50 women with inherited thrombophilia (26 Conventional and 24 Novel) and APO in previous pregnancies were included in the study. Conventional group included factor V Leiden (FVL), prothrombin G20210A (PT) mutations and antithrombin (AT), protein S (PS), and protein C (PC) deficiency, while the Novel group included methylentetrahydrofolate-reductase (MTHFR), plasminogen activator inhibitor-1 (PAI-1), and angiotensin converting enzyme (ACE) polymorphism. APO was defined as one of the following: preterm birth (PTB), fetal growth restriction (FGR), preeclampsia (PE), intrauterine fetal death (IUFD), placental abruption (PA) and deep venous thrombosis (DVT). RESULTS: There was no difference in distribution of births and spontaneous abortions between Conventional and Novel thrombophilia in untreated pregnancies (χ(2)=2.7; p=0.100) and LMWH treated pregnancies (χ(2)=0.442; p=0.506). In untreaed pregnancies thrombophilia type did not have any impact on the frequency of FTA and MTA (χ(2)=0.14; p=0.711). In birth-ended pregnancies LMWH treatement reduced the incidence of IUFD (p=0.011) in Conventional and FGR, IUFD, and PTB in Novel thrombophilia group. CONCLUSION: The equal impact of two thrombophilia types on the pregnancy outcomes and a more favorable effect of LMWH therapy on pregnancy complications in Novel thrombophilia group point the need for Novel thrombophilias screening and the future studies on this issue should be recommended. |
format | Online Article Text |
id | pubmed-4960391 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Yonsei University College of Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-49603912016-09-01 The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome Aracic, Nada Roje, Damir Jakus, Ivana Alujevic Bakotin, Marinela Stefanovic, Vedran Yonsei Med J Original Article PURPOSE: To assess the distribution of births and spontaneous abortions, first-trimester abortion (FTA) and mid-trimester abortion (MTA), in untreated (n=128) and low molecular weight heparin (LMWH) treated pregnancies (n=50) of the same women with inherited thrombophilias and adverse pregnancy outcome (APO) in previous pregnancies. We particularly investigated the impact of LMWH on reducing the pregnancy complications in two thrombophilia types, "Conventional" and "Novel". MATERIALS AND METHODS: 50 women with inherited thrombophilia (26 Conventional and 24 Novel) and APO in previous pregnancies were included in the study. Conventional group included factor V Leiden (FVL), prothrombin G20210A (PT) mutations and antithrombin (AT), protein S (PS), and protein C (PC) deficiency, while the Novel group included methylentetrahydrofolate-reductase (MTHFR), plasminogen activator inhibitor-1 (PAI-1), and angiotensin converting enzyme (ACE) polymorphism. APO was defined as one of the following: preterm birth (PTB), fetal growth restriction (FGR), preeclampsia (PE), intrauterine fetal death (IUFD), placental abruption (PA) and deep venous thrombosis (DVT). RESULTS: There was no difference in distribution of births and spontaneous abortions between Conventional and Novel thrombophilia in untreated pregnancies (χ(2)=2.7; p=0.100) and LMWH treated pregnancies (χ(2)=0.442; p=0.506). In untreaed pregnancies thrombophilia type did not have any impact on the frequency of FTA and MTA (χ(2)=0.14; p=0.711). In birth-ended pregnancies LMWH treatement reduced the incidence of IUFD (p=0.011) in Conventional and FGR, IUFD, and PTB in Novel thrombophilia group. CONCLUSION: The equal impact of two thrombophilia types on the pregnancy outcomes and a more favorable effect of LMWH therapy on pregnancy complications in Novel thrombophilia group point the need for Novel thrombophilias screening and the future studies on this issue should be recommended. Yonsei University College of Medicine 2016-09-01 2016-06-30 /pmc/articles/PMC4960391/ /pubmed/27401656 http://dx.doi.org/10.3349/ymj.2016.57.5.1230 Text en © Copyright: Yonsei University College of Medicine 2016 http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Aracic, Nada Roje, Damir Jakus, Ivana Alujevic Bakotin, Marinela Stefanovic, Vedran The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome |
title | The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome |
title_full | The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome |
title_fullStr | The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome |
title_full_unstemmed | The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome |
title_short | The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome |
title_sort | impact of inherited thrombophilia types and low molecular weight heparin treatment on pregnancy complications in women with previous adverse outcome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960391/ https://www.ncbi.nlm.nih.gov/pubmed/27401656 http://dx.doi.org/10.3349/ymj.2016.57.5.1230 |
work_keys_str_mv | AT aracicnada theimpactofinheritedthrombophiliatypesandlowmolecularweightheparintreatmentonpregnancycomplicationsinwomenwithpreviousadverseoutcome AT rojedamir theimpactofinheritedthrombophiliatypesandlowmolecularweightheparintreatmentonpregnancycomplicationsinwomenwithpreviousadverseoutcome AT jakusivanaalujevic theimpactofinheritedthrombophiliatypesandlowmolecularweightheparintreatmentonpregnancycomplicationsinwomenwithpreviousadverseoutcome AT bakotinmarinela theimpactofinheritedthrombophiliatypesandlowmolecularweightheparintreatmentonpregnancycomplicationsinwomenwithpreviousadverseoutcome AT stefanovicvedran theimpactofinheritedthrombophiliatypesandlowmolecularweightheparintreatmentonpregnancycomplicationsinwomenwithpreviousadverseoutcome AT aracicnada impactofinheritedthrombophiliatypesandlowmolecularweightheparintreatmentonpregnancycomplicationsinwomenwithpreviousadverseoutcome AT rojedamir impactofinheritedthrombophiliatypesandlowmolecularweightheparintreatmentonpregnancycomplicationsinwomenwithpreviousadverseoutcome AT jakusivanaalujevic impactofinheritedthrombophiliatypesandlowmolecularweightheparintreatmentonpregnancycomplicationsinwomenwithpreviousadverseoutcome AT bakotinmarinela impactofinheritedthrombophiliatypesandlowmolecularweightheparintreatmentonpregnancycomplicationsinwomenwithpreviousadverseoutcome AT stefanovicvedran impactofinheritedthrombophiliatypesandlowmolecularweightheparintreatmentonpregnancycomplicationsinwomenwithpreviousadverseoutcome |